Current treatments focus on controlling inflammation and minimizing long-term damage. Learn more.

Panchkula: Two years ago, Pooja Goyal faced every parent's ultimate nightmare: the death of her only son, Ketan, to a rare ...

Normally, your immune system fights off disease and protects your body from infection. However, when you have an autoimmune disease, your immune system mistakenly attacks healthy cells, tissues and ...

A population-based study from Taiwan has evaluated the occurrence of dry eye across multiple autoimmune diseases. While dry ...

While a diagnosis of antineutrophil cytoplasmic antibodies (ANCA)–associated vasculitis, or AAV, may seem daunting, it’s important to know that this chronic autoimmune disorder is no longer the ...

New research from Memorial Sloan Kettering Cancer Center (MSK) finds the TCA cycle’s waste-management function may present an opportunity against cancer; shows how microplastics impair immune ...

Taiwanese study puts numbers to common but poorly studied phenomenon ...

FRESNO, Calif. (KFSN) -- A new line of care is now available for patients in Central California. "The new rheumatology service will provide easier access to care for rheumatological conditions," says ...

Initiating mepolizumab within 3 months of EGPA diagnosis is associated with a higher remission rate, earlier glucocorticoid withdrawal, and less damage accrual.

Imviva Biotech, a clinical-stage biotechnology company developing next-generation allogeneic CAR-T cell therapies, today announced that its abstract detailing clinical results ongoing Phase 1/2 trial ...

Learn the difference between induction and maintenance phases in ANCA-associated vasculitis (AAV) treatment, including what to expect from medications like rituximab (Rituxan).